Gastrodin activates the AMPK signaling pathway by inhibiting PRMT1 to alleviate cerebral ischemia–reperfusion injury
Brain Research · 2026
DOI: 10.1016/j.brainres.2026.150516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026. Verfasst von Jiang Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Office of Drug Clinical Trial Institution, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang 330003, Jiangxi, PR China. …. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Reperfusion Injury, Glucosides, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
The complexity of the pathological processes of cerebral ischemia-reperfusion injury (CIRI) has far impeded the success of current treatment methods. This study investigated whether gastrodin, the primary bioactive metabolite of Gastrodia elata Blume, alleviates CIRI by modulating brain microvascular endothelial cell (BMEC) function. Mice were subjected to transient middle cerebral artery occlusion (tMCAO), and human BMECs were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R) for modeling. Gastrodin improved OGD/R-induced oxidative stress and ferroptosis in BMECs dose-dependently and promoted the migration and angiogenesis of BMECs. Protein arginine N-methyltransferase 1 (PRMT1) was a downstream protein of gastrodin in BMECs, and gastrodin accelerated its degradation by mediating PRMT1 protein instability. Exogenous overexpression of PRMT1 compromised the protective effect of gastrodin in vitro and in vivo. Gastrodin activated AMP-activated protein kinase (AMPK) signaling in BMECs in a PRMT1-dependent manner, and the AMPK signaling inhibitor dorsomorphin weakened the protective effect of gastrodin. Our findings demonstrate that gastrodin activates AMPK signaling by inhibiting PRMT1 protein expression in BMECs, thereby improving ferroptosis and dysfunction in BMECs and alleviating CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Office of Drug Clinical Trial Institution, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang 330003, Jiangxi, PR China. Electronic address: ljmedicine@sina.com.
- Department of Research, Kangtai Medical Laboratory Services Hebei Co., Ltd, Langfang 065500, Hebei, PR China.
- Department of Classical Chinese Medicine, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang 330003, Jiangxi, PR China.
- Department of Pharmacy, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang 330003, Jiangxi, PR China.
- Department of Cardiology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang 330003, Jiangxi, PR China.
Förderung
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Luo, J., Zhang, X., Dong, S., Yang, C., Huang, X., & Yao, X. (2026). Gastrodin activates the AMPK signaling pathway by inhibiting PRMT1 to alleviate cerebral ischemia–reperfusion injury. Brain Research. https://doi.org/10.1016/j.brainres.2026.150516
Vancouver
Luo J, Zhang X, Dong S, Yang C, Huang X, Yao X. Gastrodin activates the AMPK signaling pathway by inhibiting PRMT1 to alleviate cerebral ischemia–reperfusion injury. Brain Research. 2026. doi:10.1016/j.brainres.2026.150516
BibTeX
@article{Luo2026,
author = {Luo, Jiang and Zhang, Xian and Dong, Shuanghu and Yang, Congying and Huang, Xuedi and Yao, Xiaoyang},
title = {Gastrodin activates the AMPK signaling pathway by inhibiting PRMT1 to alleviate cerebral ischemia–reperfusion injury},
journal = {Brain Research},
year = {2026},
doi = {10.1016/j.brainres.2026.150516}
}
EUVIMED